GC Biopharma Introduces Advanced Technology for Enhanced IVIG Safety Monitoring GC Biopharma has developed a groundbreaking assay to improve the safety profile of intravenous immunoglobulin by accurately detecting impurities linked to thromboembolic risks.

GC Biopharma Introduces Advanced Technology for Enhanced IVIG Safety Monitoring #South_Korea #GC_Biopharma #Yongin #IVIG_therapy #Factor_XI